These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 21078583)
1. A case of levetiracetam-induced thrombocytopenia. Oghlakian R; Nock C; Koubeissi M Epileptic Disord; 2010 Dec; 12(4):335-7. PubMed ID: 21078583 [TBL] [Abstract][Full Text] [Related]
2. Thrombocytopenia as an adverse effect of levetiracetam therapy in a child. Peer Mohamed B; Prabhakar P Neuropediatrics; 2009 Oct; 40(5):243-4. PubMed ID: 20221962 [TBL] [Abstract][Full Text] [Related]
3. Levetiracetam-induced thrombocytopenia among inpatients: a retrospective study. Sahaya K; Goyal MK; Sarwal A; Singh NN Epilepsia; 2010 Dec; 51(12):2492-5. PubMed ID: 21204814 [TBL] [Abstract][Full Text] [Related]
8. Levetiracetam-induced thrombocytopenia in a patient with status epilepticus. Kim J; Shin JW Epileptic Disord; 2017 Mar; 19(1):104-108. PubMed ID: 28202425 [TBL] [Abstract][Full Text] [Related]
9. Levetiracetam monotherapy in children with epilepsy. Khurana DS; Kothare SV; Valencia I; Melvin JJ; Legido A Pediatr Neurol; 2007 Apr; 36(4):227-30. PubMed ID: 17437904 [TBL] [Abstract][Full Text] [Related]
10. Unexpected gamma glutamyltransferase rise increase during levetiracetam monotherapy. Broli M; Provini F; Naldi I; Bisulli F; Sama C; Baruzzi A; Tinuper P; Riva R Epileptic Disord; 2010 Mar; 12(1):81-2. PubMed ID: 20159672 [TBL] [Abstract][Full Text] [Related]
11. Add-on levetiracetam in children and adolescents with refractory epilepsy: results of an open-label multi-centre study. Callenbach PM; Arts WF; ten Houten R; Augustijn P; Gunning WB; Peeters EA; Weber AM; Stroink H; Geerts Y; Geerts AT; Brouwer OF Eur J Paediatr Neurol; 2008 Jul; 12(4):321-7. PubMed ID: 17950011 [TBL] [Abstract][Full Text] [Related]
12. Levetiracetam: new preparation. For some patients with refractory partial epilepsy. Prescrire Int; 2003 Apr; 12(64):53-4. PubMed ID: 12674114 [TBL] [Abstract][Full Text] [Related]
15. The place of levetiracetam in the treatment of epilepsy. Leppik IE Epilepsia; 2001; 42 Suppl 4():44-5. PubMed ID: 11564126 [No Abstract] [Full Text] [Related]
16. Status gelasticus associated with levetiracetam as add-on treatment. Pustorino G; Spano M; Sgro DL; Di Rosa G; Tricomi G; Bellantone D; Tortorella G Epileptic Disord; 2007 Jun; 9(2):186-9. PubMed ID: 17525032 [TBL] [Abstract][Full Text] [Related]
17. Psychic disturbances associated with sodium valproate plus levetiracetam. Siniscalchi A; Gallelli L; De Fazio S; De Sarro G Ann Pharmacother; 2007 Mar; 41(3):527-8. PubMed ID: 17327289 [No Abstract] [Full Text] [Related]
18. Levetiracetam in focal epilepsy and hepatic porphyria: a case report. Paul F; Meencke HJ Epilepsia; 2004 May; 45(5):559-60. PubMed ID: 15101839 [TBL] [Abstract][Full Text] [Related]
19. Levetiracetam-induced seizure aggravation associated with continuous spikes and waves during slow sleep in children with refractory epilepsies. Caraballo RH; Cersósimo R; De los Santos C Epileptic Disord; 2010 Jun; 12(2):146-50. PubMed ID: 20483715 [TBL] [Abstract][Full Text] [Related]
20. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial. Levisohn PM; Mintz M; Hunter SJ; Yang H; Jones J; Epilepsia; 2009 Nov; 50(11):2377-89. PubMed ID: 19702752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]